RT Journal Article
SR Electronic
T1 Expected reduction in obesity of a 20% and 30% tax to Sugar-Sweetened-Beverages in Brazil: a modeling study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.01.25.23285038
DO 10.1101/2023.01.25.23285038
A1 Basto-Abreu, Ana
A1 Torres-Alvarez, Rossana
A1 Barrientos-Gutierrez, Tonatiuh
A1 Pereda, Paula
A1 Duran, Ana Clara
YR 2023
UL http://medrxiv.org/content/early/2023/01/28/2023.01.25.23285038.abstract
AB Background The consumption of sugar-sweetened beverages (SSB) is associated with obesity, metabolic diseases, and incremental healthcare costs. Given their health consequences, the World Health Organization (WHO) recommended that countries implement taxes to SSB. Over the last 10 years, Brazil has almost doubled its obesity prevalence, yet, in 2016, the Brazilian government cut 23 percentage points to existing federal SSB taxes to their current 4%. To simulate the potential impact of updating the fiscal policy towards SSB in Brazil, we aimed to estimate the price-elasticity of SSB and model the potential impact of a new 20 or 30% excise SSB tax on consumption, obesity prevalence, and healthcare costs.Methods and Findings Using household purchases data from the Brazilian Household Budget Survey (POF) from 2017/2018, we estimated constant elasticity regressions using a log-log specification by income level for all beverage categories: (1) sugar-sweetened beverages, (2) alcoholic beverages, (3) other beverages, and (4) low-calorie sweetened beverages. We estimated baseline intake for each beverage group using 24h dietary recall data from POF 2017/2018. Applying the price and cross-price elasticities to the baseline intake, we obtained changes in caloric intake. The caloric reduction was introduced into an individual dynamic model to estimate changes in weight and obesity prevalence. By multiplying the reduction in obesity cases during 10 years by the obesity costs per capita, we predicted the reduction in obesity costs attributable to the sweetened beverage tax. SSB price elasticities were higher in the low (−1.24) than in the high-income tertile (−1.13); cross-price elasticities suggest SSB were weakly substituted by milk, water, and 100% fruit juices. We estimated a caloric change of -17.3 kcal/day/person under a 20% excise tax and -25.9 kcal/day/person for a 30% tax. 10 years after implementation, a 20% tax is expected to reduce obesity prevalence by 6.7% and 9.1% for a 30% tax. These reductions translate into a -2.8 million and -3.8 million obesity cases for a 20 and 30% tax, respectively, and a reduction of $US -257.4 million and $US -345.9 million obesity costs over 10 years for a 20 and 30% tax, respectively.Conclusions Adding a 20 to 30% excise tax on top of Brazil’s current federal tax in Brazil could help reduce the consumption of ultra-processed beverages, empty calories, and body weight while avoiding large health-related costs. Given the recent cuts to SSB taxes in Brazil, a program to revise and implement excise taxes could prove beneficial for the Brazilian population.Competing Interest StatementThe authors have declared no competing interest.Funding StatementABA,RTA, TBG, PP, ACD are funded by a grant awarded by Bloomberg Philanthropies through a sub award agreement (5104695) between the University of North Carolina at Chapel Hill and the University of Sao Paulo Center for Epidemiological Studies in Nutrition and Health, Brazil. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll relevant data are within the manuscript and its Supporting Information files.